Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:PVTTF
DataHoraFonteTítuloCódigoCompanhia
05/05/201418:22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
07/10/201317:39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201309:54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201314:49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201314:46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
05/09/201313:45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201316:24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201316:11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201301:44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201301:33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/05/201313:34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
07/05/201311:55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/05/201313:07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201319:08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
29/04/201321:38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
16/04/201316:00ZacksPivotal Progresses with Vascazen - Analyst BlogUSOTC:PVTTFPivotal Therapeutics Inc (CE)
09/04/201309:45OTC MarketsPivotal Therapeutics VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at t...USOTC:PVTTFPivotal Therapeutics Inc (CE)
06/03/201314:42OTC MarketsPivotal Therapeutics Exhibiting at the American College of Cardiology's 62nd Annual Scientific Session and EXPOUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/11/201221:12OTC MarketsHome Country News ReleaseUSOTC:PVTTFPivotal Therapeutics Inc (CE)
28/05/201217:31GlobeNewswire Inc.Pivotal Therapeutics Reports 1st Quarter 2012 ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:PVTTF